You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Goserelin

Showing 26 - 50 of 340
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence Trial (triptorelin, goserelin, leuprorelin)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • triptorelin, goserelin, leuprorelin
  • (no location specified)
Mar 10, 2023

Strength, Aging, and Memory in Prostate Cancer

Active, not recruiting
  • Prostate Neoplasm
  • Prostate Cancer
  • Androgen deprivation therapy
  • Omaha, Nebraska
    University of Nebraska Medical Center
Jul 13, 2022

Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)

Active, not recruiting
  • Breast Neoplasms
  • Perjeta Injectable Product
  • +13 more
  • Mönchengladbach, Germany
    Evangelisches Krankenhaus Bethesda Mönchengladbach
Oct 4, 2022

Salivary Duct Carcinoma Trial in Nijmegen (Goserelin 10.8 mg, Bicalutamide 50 mg, Dutasteride 0.5 mg)

Not yet recruiting
  • Salivary Duct Carcinoma
  • Goserelin 10.8 mg
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Aug 23, 2022

Endometriosis Trial in Tirana, Sofia, Rome (degarelix, goserelin)

Completed
  • Endometriosis
  • Tirana, Albania
  • +2 more
Feb 10, 2022

Androgen Deprivation-related Sarcopenia

Recruiting
  • Metastatic Prostate Cancer
  • Androgen Deprivation Therapy
  • GnRH agonist
  • Seattle, Washington
    Veterans Affairs Puget Sound Health Care System
Mar 16, 2022

Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

Recruiting
  • Salivary Gland Cancer
  • Nagoya, Aichi, Japan
  • +11 more
Jan 21, 2023

Prostate Cancer Trial in Canada, Georgia (Goserelin Acetate)

Completed
  • Prostate Cancer
  • Goserelin Acetate
  • Abbotsford, British Columbia, Canada
  • +6 more
May 6, 2021

Breast Tumor, Breast Cancer, Hormone Receptor Positive Tumor Trial in Shanghai (PIK3CA inhibitor, AKT inhibitor, Carrelizumab)

Recruiting
  • Breast Neoplasm
  • +4 more
  • PIK3CA inhibitor
  • +12 more
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jan 2, 2023

Metastatic Breast Cancer Trial in Chuo-ku, Nihonbashi, Koami-cho (Paclitaxel, Bevacizumab, Letrozole)

Completed
  • Metastatic Breast Cancer
  • Chuo-ku, Nihonbashi, Koami-cho, Tokyo, Japan
    Japan Breast Cancer Research Group
Aug 2, 2022

Breast Tumors Trial in Worldwide (Palbociclib, Placebo, Tamoxifen)

Active, not recruiting
  • Breast Neoplasms
  • Nagoya, Aichi, Japan
  • +22 more
Apr 4, 2022

Breast Cancer Trial in Prato (Ribociclib, Aromatase Inhibitors, non steroideal, LHRH agonist)

Recruiting
  • Breast Cancer
  • Prato, Please Select:, Italy
    Hospital of Prato
Jul 27, 2022

Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • (no location specified)
Aug 10, 2022

Prostate Cancer Trial in Douliu City/Huwei Township, Tapiei (radiation, drug, procedure)

Recruiting
  • Prostate Cancer
  • radiation therapy
  • +2 more
  • Douliu City/Huwei Township, Yunlin County, Taiwan
  • +1 more
Apr 5, 2022

Breast Cancer, Breast Carcinoma, Cancer of Breast Trial in Saint Louis, Lincoln (Palbociclib, Letrozole, Fulvestrant)

Active, not recruiting
Has Results
  • Breast Cancer
  • +3 more
  • Saint Louis, Missouri
  • +1 more
Jul 20, 2022

Breast Cancer Trial in Budapest (Tamoxifen, Goserelin, Letrozole 2.5Mg Tab)

Not yet recruiting
  • Breast Cancer
  • Budapest, Hungary
    National Institute of Oncolgy
Nov 20, 2021

Breast Tumor, Breast Cancer, Breast Tumors Trial in Shanghai (Dalpiciclib, Pyrotinib, SHR-A1811)

Not yet recruiting
  • Breast Neoplasm
  • +9 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Oct 13, 2022

Prostate Cancer Trial in Brazil (Leuprorelin Acetate (Eligard® 45 mg).)

Completed
  • Prostate Cancer
  • Leuprorelin Acetate (Eligard® 45 mg).
  • Porto Alegre, RS, Brazil
  • +5 more
Mar 21, 2022

Invasive Lobular Breast Carcinoma, ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Belgium, France (Entrectinib,

Recruiting
  • Invasive Lobular Breast Carcinoma
  • +2 more
  • Brussels, Belgium
  • +9 more
May 4, 2022

Early-stage Breast Cancer Trial (Cyclophosphamide, Methotrexate, Fluorouracil implant)

Completed
  • Early-stage Breast Cancer
  • (no location specified)
Oct 13, 2020

Prostate Cancer Trial in Sherbrooke (Radiotherapy 70 Gy, Radiotherapy 76 Gy, Androgen blockade)

Active, not recruiting
  • Prostate Cancer
  • Radiotherapy 70 Gy
  • +2 more
  • Sherbrooke, Quebec, Canada
    Centre de Recherche Clinique du CHUS
May 20, 2022

Bioequivalence Trial (XM17, Gonal-f®, Zoladex®)

Completed
  • Bioequivalence
  • (no location specified)
Nov 5, 2021

Salivary Gland Carcinoma Trial in United States (Goserelin Acetate, Pembrolizumab)

Recruiting
  • Salivary Gland Carcinoma
  • Chicago, Illinois
  • +6 more
Sep 22, 2022

PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Duarte, South Pasadena (drug, radiation, other)

Active, not recruiting
Has Results
  • PSA Level Greater Than Two
  • Stage IV Prostate Adenocarcinoma AJCC v7
  • Duarte, California
  • +1 more
Apr 4, 2022

Breast Cancer Trial in Los Angeles, Bronx (Gedatolisib, Faslodex, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Los Angeles, California
  • +1 more
Jan 25, 2022